Pfizer (PFE) Minority Interest (2009 - 2026)

Pfizer (PFE) has 18 years of Minority Interest data on file, last reported at $303.0 million in Q1 2026.

• Minority Interest for Q1 2026 came in at $303.0 million, up 1.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $303.0 million (up 1.34% YoY), and the FY2025 annual result was $299.0 million, up 1.7% from the prior year.
• Minority Interest climbed to $303.0 million in Q1 2026 per PFE's latest filing, from $299.0 million in the prior quarter.
• Over five years, Minority Interest peaked at $317.0 million in Q2 2025 and troughed at $227.0 million in Q4 2022.
• A 5-year average of $277.6 million and a median of $274.0 million in 2023 frame the typical range for Minority Interest.
• The sharpest annual moves came in 2022 and 2023: Minority Interest decreased 18.64% in 2022, then grew 18.94% in 2023.
• A 5-year view of Minority Interest shows it stood at $256.0 million in 2022, then increased by 7.03% to $274.0 million in 2023, then gained by 7.3% to $294.0 million in 2024, then advanced by 1.7% to $299.0 million in 2025, then rose by 1.34% to $303.0 million in 2026.
• Business Quant data shows PFE's Minority Interest at $303.0 million in Q1 2026, $299.0 million in Q4 2025, and $295.0 million in Q3 2025.